Skip to main content
Fig. 1 | Journal of Neuroinflammation

Fig. 1

From: A co-ultramicronized palmitoylethanolamide/luteolin composite mitigates clinical score and disease-relevant molecular markers in a mouse model of experimental autoimmune encephalomyelitis

Fig. 1

Dose-dependent effect of PEALut, started at 11 PID, on neurologic score severity in MOG35-55 immunized mice. All mice were immunized with MOG35-55 and treated with PEALut at doses of 0.1, 1, and 5 mg/kg or corresponding Veh. PEALut treatments started at 11 PID. Data are presented as means ± SD. n = 8 for each experimental group. *p = 0.04; **p = 0.004. Newman-Keuls post hoc test

Back to article page

Journal of Neuroinflammation

ISSN: 1742-2094